Application
19426699 · METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY
Filed 2025-12-19 · Granted · Patent 12669498 (2026-06-30) The official file ↗The patent and its PDF ↗ · Art unit 1657 · Examiner Satyendra K Singh Typical · CPC A61M 5/168 · Horizon Therapeutics USA, Inc. · AMGEN INC.
Office actions
0
first was Notice of allowance
RCEs
0
no appeal
To first action
3.6 mo
to disposition 6.3 mo
Statutes raised
·
0 actions read